Science Explorer Interactive view Map
Company · Madison · United States

Cellectar Biosciences (United States)

cellectarbiosciences.comROR OpenAlex
Research works
32
▼ 18% vs 2013–17
Citations
1.3k
40.2 per fractional work
Top-10% rate
7.9%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Cellectar Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.08× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.25× its world share, 0 worksImmunology and Micro…Neuroscience: 2.76× its world share, 0 worksNeuroscienceEngineering: 1.04× its world share, 0 worksEngineeringPhysics and Astronomy: 2.62× its world share, 0 worksPhysics and AstronomyMedicine: 1.60× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.1×. Every wedge is a field page.

Which keywords describe research at Cellectar Biosciences (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Immunotherapy, Dosimetry, PET Imaging, Cancer Treatment, Radioimmunotherapy, Radiopharmaceuticals and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Targeted Therapy4▲ 59×4 topics
  2. Dosimetry3▲ 111×2 topics
  3. Immunotherapy3▲ 16×7 topics
  4. Cancer Treatment3▲ 37×2 topics
  5. PET Imaging3▲ 45×2 topics
  6. Radioimmunotherapy3▲ 230×1 topic
  7. Radiopharmaceuticals3▲ 230×1 topic
  8. Cancer3▲ 5.8×7 topics
  9. Tumor Microenvironment2▲ 22×2 topics
  10. HIF-12▲ 92×1 topic
  11. Warburg Effect2▲ 92×1 topic
  12. Chemotherapy2▲ 7.7×6 topics
  13. Gene Therapy2▲ 17×3 topics
  14. Tumor Targeting2▲ 35×3 topics
  15. Clinical Trials1▲ 7.0×3 topics
  16. Radiotherapy1▲ 11×5 topics
  17. Low Back Pain1▲ 25×2 topics
  18. Mesenchymal Stem Cells1▲ 33×3 topics
  19. Regeneration1▲ 21×2 topics
  20. Cholesterol1▲ 18×2 topics
  21. Inflammation1▲ 1.51×6 topics
  22. Prognostic Factors1▲ 7.7×5 topics
  23. Quantitative1▲ 29×2 topics
  24. Staging System1▲ 53×2 topics
  25. Degenerative Disc Disease1▲ 34×2 topics
  26. Imaging1▲ 9.1×1 topic
  27. PET/CT1▲ 43×1 topic
  28. Tumor Regression1▲ 36×2 topics

Which research topics does Cellectar Biosciences (United States) publish most on?

By volume in 2022–2025: Nanoplatforms for cancer theranostics, ATP Synthase and ATPases Research, Cancer, Hypoxia, and Metabolism and Extracellular vesicles in disease.

Nanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksATP Synthase and ATPases…0ATP Synthase and ATPases Research: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksExtracellular vesicles i…0Extracellular vesicles in disease: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksAdvanced Radiotherapy Techniques: 0 fractional worksSingle-cell and spatial …0Single-cell and spatial transcriptomics: 0 fractional worksMicrofluidic and Bio-sensing Technologies: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional works
Biomedical EngineeringMolecular BiologyCancer ResearchGenetics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  2. 2 ATP Synthase and ATPases Research Molecular Biology 0 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  4. 4 Extracellular vesicles in disease Molecular Biology 0 works
  5. 5 Glioma Diagnosis and Treatment Genetics 0 works
  6. 6 Advanced Radiotherapy Techniques Radiation 0 works
  7. 7 Single-cell and spatial transcriptomics Molecular Biology 0 works
  8. 8 Microfluidic and Bio-sensing Technologies Biomedical Engineering 0 works
  9. 9 RNA Interference and Gene Delivery Molecular Biology 0 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.8%not open65.2%

World: 28% of research is openly available.

with international co-authors10.2%domestic only89.8%

World: 19% is written across borders.

How has Cellectar Biosciences (United States)'s research output changed?

Output in 2018–2022 was 18% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madison

All research institutions in Madison

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.